|
1.
|
A MantovaniP AllavenaA SicaF
BalkwillCancer-related
inflammationNature454436444200810.1038/nature07205
|
|
2.
|
I ChengJS WitteSJ JacobsenProstatitis,
sexually transmitted diseases, and prostate cancer: the California
Men’s Health StudyPLoS One5e87362010
|
|
3.
|
S JafariM EtminanK AfsharNonsteroidal
anti-inflammatory drugs and prostate cancer: a systematic review of
the literature and meta-analysisCan Urol Assoc
J3323330200919672448
|
|
4.
|
AM De MarzoEA PlatzS SutcliffeInflammation
in prostate carcinogenesisNat Rev Cancer72562692007
|
|
5.
|
G PerlettiE MontanariA VralG GazzanoE
MarrasS MioneV MagriInflammation, prostatitis, proliferative
inflammatory atrophy: ‘Fertile ground’ for prostate cancer
development?Mol Med Rep33122010
|
|
6.
|
ON KryvenkoM JankowskiDA ChitaleD TangA
RundleS TrudeauBA RybickiInflammation and preneoplastic lesions in
benign prostate as risk factors for prostate cancerMod
Pathol2510231032201210.1038/modpathol.2012.5122460812
|
|
7.
|
S DavidssonM FiorentinoO
AndrénInflammation, focal atrophic lesions, and prostatic
intraepithelial neoplasia with respect to risk of lethal prostate
cancerCancer Epidemiol Biomarkers
Prev2022802287201110.1158/1055-9965.EPI-11-0373
|
|
8.
|
MJ PutziAM De MarzoMorphologic transitions
between proliferative inflammatory atrophy and high-grade prostatic
intraepithelial
neoplasiaUrology56828832200010.1016/S0090-4295(00)00776-7
|
|
9.
|
W WangA BerghJE DamberMorphological
transition of proliferative inflammatory atrophy to high-grade
intraepithelial neoplasia and cancer in human
prostateProstate6913781386200910.1002/pros.2099219507201
|
|
10.
|
A BillisLL FreitasLA MagnaU
FerreiraInflammatory atrophy on prostate needle biopsies: is there
topographic relationship to cancer?Int Braz J
Urol33355360200710.1590/S1677-55382007000300008
|
|
11.
|
AA BrasilWJ FavaroVH CagnonU FerreiraA
BillisAtrophy in specimens of radical prostatectomy: is there
topographic relation to high grade prostatic intraepithelial
neoplasia or cancer?Int Urol
Nephrol43397403201110.1007/s11255-010-9803-y
|
|
12.
|
A BillisProstatic atrophy.
Clinicopathological significanceInt Braz J
Urol36401409201010.1590/S1677-5538201000040000320815946
|
|
13.
|
RC AntonMW KattanS ChakrabortyTM
WheelerPostatrophic hyperplasia of the prostate: lack of
association with prostate cancerAm J Surg
Pathol23932936199910.1097/00000478-199908000-0001110435563
|
|
14.
|
R PostmaFH SchröderTH van der KwastAtrophy
in prostate needle biopsy cores and its relationship to prostate
cancer incidence in screened
menUrology65745749200510.1016/j.urology.2004.10.04615833520
|
|
15.
|
G MikuzF AlgabaAL BeltranR
MontironiProstate carcinoma: atrophy or not atrophy that is the
questionEur
Urol5212931296200710.1016/j.eururo.2007.07.03917761384
|
|
16.
|
R MontironiR MazzucchelliA Lopez-BeltranL
ChengM ScarpelliMechanisms of disease: high-grade prostatic
intraepithelial neoplasia and other proposed preneoplastic lesions
in the prostateNat Clin Pract
Urol4321332200710.1038/ncpuro081517551536
|
|
17.
|
KS SfanosAM De MarzoProstate cancer and
inflammation: the
evidenceHistopathology60199215201210.1111/j.1365-2559.2011.04033.x22212087
|
|
18.
|
S Yildiz-SezerI VerdorferG SchaeferH
RogatschG BartschG MikuzAssessment of aberrations on chromosome 8
in prostatic atrophyBJU
Int98184188200610.1111/j.1464-410X.2006.06233.x16831166
|
|
19.
|
JA MacoskaTM TrybusKJ Wojno8p22 loss
concurrent with 8c gain is associated with poor outcome in prostate
cancerUrology55776782200010.1016/S0090-4295(00)00468-410792100
|
|
20.
|
R ShahNR MucciA AminJA MacoskaMA
RubinPostatrophic hyperplasia of the prostate gland: neoplastic
precursor or innocent bystander?Am J
Pathol15817671773200110.1016/S0002-9440(10)64132-611337374
|
|
21.
|
S Yildiz-SezerI VerdorferG SchaeferH
RogatschG BartschG MikuzGain of chromosome X in prostatic atrophy
detected by CGH and FISH
analysesProstate67433438200710.1002/pros.2053517219381
|
|
22.
|
KS SfanosBA WilsonAM De MarzoWB
IsaacsAcute inflammatory proteins constitute the organic matrix of
prostatic corpora amylacea and calculi in men with prostate
cancerProc Natl Acad Sci
USA10634433448200910.1073/pnas.081047310619202053
|
|
23.
|
M ScarpelliR MazzucchelliF BarbisanA
SantinelliA Lopez-BeltranL ChengR MontironiIs there a role for
prostate tumour overexpressed-1 in the diagnosis of HGPIN and of
prostatic adenocarcinoma? A comparison with alpha-methylacyl CoA
racemaseInt J Immunopathol Pharmacol256774201222507319
|
|
24.
|
V FradetI ChengG CaseyJS WitteDietary
omega-3 fatty acids, cycloxygenase-2 genetic variation, and
aggressive prostate cancer riskClin Cancer
Res1525591566200910.1158/1078-0432.CCR-08-250319318492
|
|
25.
|
JN KriegerL Nyberg JrJC NickelNIH
consensus definition and classification of
prostatitisJAMA282236237199910.1001/jama.282.3.23610422990
|
|
26.
|
V MagriE MontanariV
ŠkerkFluoroquinolone-macrolide combination therapy for chronic
bacterial prostatitis: retrospective analysis of pathogen
eradication rates, inflammatory findings and sexual
dysfunctionAsian J Androl13819827201110.1038/aja.2011.36
|
|
27.
|
V MagriA TrinchieriE MontanariReduction of
PSA values by combination pharmacological therapy in patients with
chronic prostatitis: implications for prostate cancer detectionArch
Ital Urol Androl7984922007
|
|
28.
|
JC NickelLD TrueJN KriegerRE BergerAH
BoagID YoungConsensus development of a histopathological
classification system for chronic prostatic inflammationBJU
Int87797805200110.1046/j.1464-410x.2001.02193.x11412216
|
|
29.
|
L SongY ZhuP HanN ChenD LinJ LaiQ WeiA
retrospective study: correlation of histologic inflammation in
biopsy specimens of Chinese men undergoing surgery for benign
prostatic hyperplasia with serum prostate-specific
antigenUrology77688692201110.1016/j.urology.2010.07.493
|
|
30.
|
AM De MarzoEA PlatzJI EpsteinA working
group classification of focal prostate atrophy lesionsAm J Surg
Pathol3012811291200617001160
|
|
31.
|
A BillisL MeirellesLL FreitasLA MagnaU
FerreiraDoes the type of prostatic atrophy influence the
association of extent of atrophy in needle biopsies and serum
prostate-specific antigen
levels?Urology7411111115200910.1016/j.urology.2009.05.093
|
|
32.
|
R MontironiR MazzucchelliF AlgabaA
Lopez-BeltranMorphological identification of the patterns of
prostatic intraepithelial neoplasia and their importanceJ Clin
Pathol53655665200010.1136/jcp.53.9.65511041054
|
|
33.
|
R MontironiM ScarpelliR MazzucchelliL
ChengA Lopez-BeltranThe spectrum of morphology in non-neoplastic
prostate including cancer
mimicsHistopathology604158201210.1111/j.1365-2559.2011.04000.x22212077
|
|
34.
|
MS LitwinM McNaughton-CollinsFJ Fowler
JrThe National Institutes of Health chronic prostatitis symptom
index: development and validation of a new outcome measureJ
Urol162369375199910.1016/S0022-5347(05)68562-X
|
|
35.
|
F YatesContingency tables involving small
numbers and the χ2 testJ R Stat Soc12172351934
|
|
36.
|
A BillisLA MagnaInflammatory atrophy of
the prostate. Prevalence and significanceArch Pathol Lab
Med127840844200312823038
|
|
37.
|
KM RuskaJ SauvageotJI EpsteinHistology and
cellular kinetics of prostatic atrophyAm J Surg
Pathol2210731077199810.1097/00000478-199809000-000059737239
|
|
38.
|
JE McNealNormal histology of the
prostateAm J Surg
Pathol12619633198810.1097/00000478-198808000-000032456702
|
|
39.
|
JR SrigleyBenign mimickers of prostatic
adenocarcinomaMod Pathol17328348200410.1038/modpathol.3800055
|
|
40.
|
A BillisL MeirellesLL FreitasMergence of
partial and complete atrophy in prostate needle biopsies: a
morphologic and immunohistochemical studyVirchows
Arch456689694201010.1007/s00428-010-0904-x20361207
|
|
41.
|
Foundations of Clinical Research:
Applications and PracticeLG PortneyMP WatkinsAppleton &
LangeNorwalk, Connecticut5095161993
|
